Dis-Chem Pharmacies Balance Sheet Health
Financial Health criteria checks 6/6
Dis-Chem Pharmacies has a total shareholder equity of ZAR4.5B and total debt of ZAR2.6B, which brings its debt-to-equity ratio to 58.6%. Its total assets and total liabilities are ZAR17.5B and ZAR13.0B respectively. Dis-Chem Pharmacies's EBIT is ZAR1.8B making its interest coverage ratio 4. It has cash and short-term investments of ZAR884.4M.
Key information
58.6%
Debt to equity ratio
R2.62b
Debt
| Interest coverage ratio | 4x |
| Cash | R884.37m |
| Equity | R4.47b |
| Total liabilities | R13.03b |
| Total assets | R17.50b |
Recent financial health updates
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well
Aug 21
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Feb 26Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Aug 16Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Jun 08Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?
Feb 23Recent updates
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well
Aug 21Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price
Jun 06Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around
Apr 17Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Feb 26Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively
Dec 30If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity
Sep 07Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Aug 16Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends
Jul 31Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
May 09There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Mar 29Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
Jan 14Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture
Nov 04Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate
Oct 04We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Sep 01Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Jul 04A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)
Jun 21Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Jun 08The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts
May 25Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?
Feb 23Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings
Feb 08I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Dec 13Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality
Nov 09Financial Position Analysis
Short Term Liabilities: DCP's short term assets (ZAR10.9B) exceed its short term liabilities (ZAR9.2B).
Long Term Liabilities: DCP's short term assets (ZAR10.9B) exceed its long term liabilities (ZAR3.8B).
Debt to Equity History and Analysis
Debt Level: DCP's net debt to equity ratio (38.8%) is considered satisfactory.
Reducing Debt: DCP's debt to equity ratio has reduced from 60.3% to 58.6% over the past 5 years.
Debt Coverage: DCP's debt is well covered by operating cash flow (72.1%).
Interest Coverage: DCP's interest payments on its debt are well covered by EBIT (4x coverage).